NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services

Contributed by: Business Wire

Logo

Images

NJ Bio, Inc. now offers translational research services after completing asset purchase and full integration of the services of L2P® Research Labs, enhancing the discovery-to-development pipeline

Business Wire embedded0

Tags

Manufacturing

Pharmaceutical

Research

Other Technology

Oncology

Medical Devices

Science

Technology

Clinical Trials

Medical Supplies

Other Communications

General Health

Biotechnology

Health

Other Manufacturing

Communications

Apps/Applications

Engineering

Chemicals/Plastics

L2P

More Like This

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

GlobeNewswire associated0

BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies

QPS Netherlands High Resolution Mass Spectrometry Laboratory in Groningen, The Netherlands. (Photo: Business Wire)

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

Business Wire associated0

Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

PartitionBio™ awarded grant to exploit its novel biologics shuttle platform for therapeutic nucleic acids delivery

PR Newswire associated0

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics

PR Newswire associated0

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services